Medical/Pharmaceuticals
Frost & Sullivan Reported The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-scale Production of Biologics
SHANGHAI, May 29, 2024 /PRNewswire/ -- Recently, Frost & Sullivan released the report "The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-scale Production of Biologics". I. CDMOs are advancing the biopharmaceutical industry with superior biomanufacturing capabilities...
Spectacular advances creating a revolution in the diagnosis and treatment of male infertility
MANILA, Philippines, May 29, 2024 /PRNewswire/ -- Spectacular advances in the diagnosis and treatment of male infertility are offering new hope to the one in six couples globally who seek assisted reproduction to achieve their dreams of parenthood. A major conference on human reproduction in t...
US-Based Neurobiotic Leader Bened Life enters Japan market with Neuralli™ MP
FREMONT, Calif., May 29, 2024 /PRNewswire/ -- Bened Life
SKT Launches AI-powered Veterinary Diagnostic Assistance Service X Caliber in Australia
* In collaboration with ATX Medical Solutions, SKT launches X Caliber in Australia, which has one of the highest rates of pet ownership in the world * SKT also inked a commercial contract with MEDIVET Pet Hospital & Clinic to offer X Caliber inIndonesia. SEOUL, South Korea, May 29, 2024 /PRNew...
TREEFROG THERAPEUTICS PICKS-UP BEST POSTER AWARD AT THE INTERNATIONAL SOCIETY FOR CELL & GENE THERAPY (ISCT) ANNUAL MEETING FOR THEIR CELL THERAPY PROGRAM IN PARKINSON'S DISEASE
- Treefrog will present two posters on their cell therapy program in
Parkinson's Disease and their proprietary encapsulation technology, C-Stem™ -
BORDEAUX, France, May 29, 2024 /PRNewswire/ -- TreeFrog Therapeutics
GC Cell participates 2024 BIO International Convention, Unveiling its future Blueprint 2.0, as the First Korean Business Forum Sponsor
SAN DIEGO, May 28, 2024 /PRNewswire/ -- GC Cell
Rege Nephro CO., Ltd. Announces Patient Enrollment for Phase II Clinical Trial of Tamibarotene for ADPKD
KYOTO, Japan, May 28, 2024 /PRNewswire/ -- Rege Nephro CO., Ltd. (
https://www.regenephro.co.jp/en
Metabolon Now Includes Spectral Data Files for All Global Discovery Panel Projects
MORRISVILLE, N.C., May 28, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced the availability of spectral data fil...
AUVON Launches a New Professional TENS Unit "AUVON PT1 Pro", Offering a Drug-free Pain Relief Way at Home
Enjoy Convenient, Professional-grade, and Customizable Pain Relief with AUVON
7000
From Research to Practice: Prof. Gang Shen and Smartee's Contributions to the ASO Clinical Day 2024
SYDNEY, May 28, 2024 /PRNewswire/ -- Smartee Denti-Technology, a global leader in clear aligners and digital orthodontic solutions, demonstrated its commitment to transforming research into practical clinical applications at the ASO Clinical Day 2024.5.24. ASO is the largest dental specialist so...
HanAll Biopharma Signs Licensing Agreement with Turn Biotechnologies to Develop Novel Treatments for Eye and Ear Diseases
* Exclusive agreement allows HanAll to utilize Epigenetic Reprogramming of Aging (ERATM) technology for ophthalmic and otic diseases. * Collaboration aims to leverage HanAll's extensive expertise in ophthalmic and otic diseases and Turn Bio's cellular reprogramming technology to create innova...
Turn Biotechnologies Signs Global Licensing Agreement with HanAll Biopharma to Develop Eye and Ear Therapies
* Synergistic collaboration to revolutionize age-related therapies worldwide * Deal valued at over $300 million USD for initial product MOUNTAIN VIEW, Calif., May 28, 2024 /PRNewswire/ -- Turn Biotechnologies, a developer of novel mRNA medicines and enabling technologies, today announced an e...
Lifespin GmbH and Acıbadem Forge a Groundbreaking Metabolomics Partnership to Advance Personalized Medicine
ISTANBUL and REGENSBURG, Germany, May 28, 2024 /PRNewswire/ -- lifespin GmbH, a pioneer in health status detection software, has teamed up with Acıbadem University (ACU) and Acıbadem Healthcare Group (AHG) to launch a comprehensive precision medicine initiative, a significant stride towards revol...
Ovarian tissue transplantation is gaining ground for fertility preservation in young and old, with potential to offset adverse effects of menopause
MANILA, Philippines, May 28, 2024 /PRNewswire/ -- More than 10,000 women and girls around the world facing urgent treatments for cancers and other serious conditions that threatened their fertility have had their motherhood potential preserved by surgical removal and freezing of ovarian tissue. ...
Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA to the NMPA
SAN FRANCISCO and SUZHOU, China, May 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...
Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome
Highlights: * Statistically significant improvement from baseline assessed by both clinicians and caregivers in all four efficacy measures specifically designed for Pitt Hopkins syndrome (Wilcoxon signed rank test p<0.05) * Clinician and caregiver global efficacy measures showed a level of i...
Driving a consensus approach to improve the lives and fertility health of women stricken with endometriosis
MANILA, Philippines , May 27, 2024 /PRNewswire/ -- Specialists in reproductive health in theAsia Pacific region are advancing a pathfinding initiative to improve the lives of millions of women around the world who suffer from endometriosis. The debilitating condition affects up to 10 per cent ...
Chula Medicine Joins Forces with the Department of Thai Traditional and Alternative Medicine to Determine "Curcumin" as Effective Treatment for Dyspepsia as Modern Antacids
Chula
Telix Submits NDA for New Prostate Cancer Imaging Agent
MELBOURNE, Australia, May 27, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has submitted a New Drug Application (NDA) tothe United States (U.S.) Food and Drug Administration (FDA) for TLX007-CDx, a new and proprietary cold kit ("Kit") for th...
Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response
- Lunit's ASCO 2024 presentations to highlight advances including HER2 ultra-low detection and AI-powered ICI response prediction models for NSCLC, demonstrating the impact of Lunit SCOPE suite on precision oncology SEOUL, South Korea, May 24, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leadin...
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00